Literature DB >> 7647331

Transformation of estrone and estradiol in hormone-dependent and hormone-independent human breast cancer cells. Effects of the antiestrogen ICI 164,384, danazol, and promegestone (R-5020).

B L Nguyen1, G Chetrite, J R Pasqualini.   

Abstract

Using different hormone-dependent (MCF-7, T-47D) and hormone-independent (MDA-MB-231, Hs-578S, MDA-MB-436) human breast cancer cells, the interconversion estrone (E1)<-->estradiol (E2) was explored. The data show very clearly that in the hormone-dependent cells the tendency is to form E2 after incubation with E1, whereas after incubation with E2 most of this estrogen remains unchanged. In the hormone-independent cells, in contrast most of E1 remains E1, while E2 is converted into E1. The tendency of the reductive<-->oxidative direction is supported by the analysis of estrogens in the culture medium. To explore the possible action of different drugs on the 17 beta-hydroxysteroid dehydrogenase (17 beta-HSD) activity, it was observed that the potent antiestrogen ICI 164,384 inhibits the conversion of E1 to E2, while a lesser effect is observed with Danazol and only weak inhibition is obtained with the progestagen Promegestone (R-5020). It is concluded that the orientation of 17 beta-HSD activity for the interconversion E1<-->E2 in hormone-dependent and -independent cells is related to the hormonal status of the cells.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7647331     DOI: 10.1007/bf00665786

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  34 in total

1.  A study of the conditions and mechanism of the diphenylamine reaction for the colorimetric estimation of deoxyribonucleic acid.

Authors:  K BURTON
Journal:  Biochem J       Date:  1956-02       Impact factor: 3.857

2.  Effects of plasma estrogen sulfates in mammary cancer cells.

Authors:  F Vignon; M Terqui; B Westley; D Derocq; H Rochefort
Journal:  Endocrinology       Date:  1980-04       Impact factor: 4.736

Review 3.  Recent data on estrogen sulfatases and sulfotransferases activities in human breast cancer.

Authors:  J R Pasqualini; B Schatz; C Varin; B L Nguyen
Journal:  J Steroid Biochem Mol Biol       Date:  1992-03       Impact factor: 4.292

4.  Estrogen sulfates: biological and ultrastructural responses and metabolism in MCF-7 human breast cancer cells.

Authors:  J R Pasqualini; C Gelly; F Lecerf
Journal:  Breast Cancer Res Treat       Date:  1986       Impact factor: 4.872

5.  Comparison of the in vitro conversion of estradiol-17 beta to estrone of normal and neoplastic human breast tissue.

Authors:  K Pollow; E Boquoi; J Baumann; M Schmidt-Gollwitzer; B Pollow
Journal:  Mol Cell Endocrinol       Date:  1977-02       Impact factor: 4.102

6.  In situ estrogen production via the estrone sulfatase pathway in breast tumors: relative importance versus the aromatase pathway.

Authors:  S J Santner; P D Feil; R J Santen
Journal:  J Clin Endocrinol Metab       Date:  1984-07       Impact factor: 5.958

7.  Steroidal regulation of oestradiol-17 beta dehydrogenase activity of the human breast cancer cell line MCF-7.

Authors:  E F Adams; N G Coldham; V H James
Journal:  J Endocrinol       Date:  1988-07       Impact factor: 4.286

8.  17 Beta-hydroxysteroid dehydrogenases in human breast tissues: purification and characterization of soluble enzymes and the distribution of particulate and soluble forms in adipose, non-adipose and tumour tissues.

Authors:  V Z Mann; C J Newton; G H Tait
Journal:  J Mol Endocrinol       Date:  1991-08       Impact factor: 5.098

9.  Estrone sulfatase activity and effect of antiestrogens on transformation of estrone sulfate in hormone-dependent vs. independent human breast cancer cell lines.

Authors:  J R Pasqualini; B L Nguyen
Journal:  Breast Cancer Res Treat       Date:  1991-05       Impact factor: 4.872

10.  Regulation of 17 beta-hydroxysteroid dehydrogenase in a newly-established human breast carcinoma cell line.

Authors:  R R Mehta; T K Das Gupta
Journal:  J Steroid Biochem Mol Biol       Date:  1993-11       Impact factor: 4.292

View more
  8 in total

Review 1.  Structural insights into the functional versatility of WW domain-containing oxidoreductase tumor suppressor.

Authors:  Amjad Farooq
Journal:  Exp Biol Med (Maywood)       Date:  2015-02-07

2.  Acetylation targets HSD17B4 for degradation via the CMA pathway in response to estrone.

Authors:  Ye Zhang; Ying-Ying Xu; Chuan-Bo Yao; Jin-Tao Li; Xiang-Ning Zhao; Hong-Bin Yang; Min Zhang; Miao Yin; Jing Chen; Qun-Ying Lei
Journal:  Autophagy       Date:  2017-02-22       Impact factor: 16.016

3.  17beta-hydroxysteroid dehydrogenase type 1 stimulates breast cancer by dihydrotestosterone inactivation in addition to estradiol production.

Authors:  Juliette A Aka; Mausumi Mazumdar; Chang-Qing Chen; Donald Poirier; Sheng-Xiang Lin
Journal:  Mol Endocrinol       Date:  2010-02-19

4.  The Role of Androgens in Normal and Malignant Breast Tissue.

Authors:  Katharina Tiefenbacher; Günter Daxenbichler
Journal:  Breast Care (Basel)       Date:  2008-10-16       Impact factor: 2.860

5.  17beta-hydroxysteroid dehydrogenase type 1 modulates breast cancer protein profile and impacts cell migration.

Authors:  Juliette A Aka; Mouna Zerradi; François Houle; Jacques Huot; Sheng-Xiang Lin
Journal:  Breast Cancer Res       Date:  2012-06-12       Impact factor: 6.466

6.  Intratumoural mRNA expression of genes from the oestradiol metabolic pathway and clinical and histopathological parameters of breast cancer.

Authors:  Noriko Yoshimura; Nobuhiro Harada; Ida Bukholm; Rolf Kåresen; Anne-Lise Børresen-Dale; Vessela N Kristensen
Journal:  Breast Cancer Res       Date:  2003-12-11       Impact factor: 6.466

7.  Estradiol-17β Regulates Expression of Luteal DNA Methyltransferases and Genes Involved in the Porcine Corpus Luteum Function In Vivo.

Authors:  Piotr Kaczynski; Monika Baryla; Ewelina Goryszewska; Agnieszka Waclawik
Journal:  Int J Mol Sci       Date:  2021-04-01       Impact factor: 5.923

8.  Alteration of oestradiol metabolism in myc oncogene-transfected mouse mammary epithelial cells.

Authors:  N T Telang; F Arcuri; O M Granata; H L Bradlow; M P Osborne; L Castagnetta
Journal:  Br J Cancer       Date:  1998-05       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.